Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532983 | NSE Symbol : RPGLIFE | ISIN : INE105J01010 | Industry : Pharmaceuticals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
17-Jan-2025	24-Jan-2025	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday January 24 2025 inter-alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2024. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from January 1 2025 and will continue to remain closed till 48 hours after the results are made public on January 24 2025. Kindly take this information on record. The Company has informed Exchange regarding Board approval for revision in the Code of Conduct under SEBI (PIT) Regulations, 2015. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Friday, January 24, 2025, inter-alia, considered and approved the 1. Unaudited Financial Results of the Company for the quarter ended December 31, 2024 and Intimation about change in Code/Policy. (As Per Bse Announcement Dated on 24.01.2025)
31-Oct-2024	07-Nov-2024	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Thursday November 7 2024 inter-alia to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30 2024. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from October 1 2024 and will continue to remain closed till 48 hours after the results are made public on November 7 2024. As per SEBI (LODR), please find attached herewith the UFR of the Company for the quarter and half year ended September 30, 2024 (As Per BSE Announcement Dated on: 07/11/2024)
13-Sep-2024	13-Sep-2024	Others	Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) regulations, 2015 and other applicable provisions, this is to inform you that the Board of Directors at its meeting held today which commenced at 2:00 pm and concluded at 3:15 pm, has unanimously approved the matter as attached . Disclosures as required under SEBI Circular No. dated July 13, 2023, are enclosed herewith as Annexure - A and Annexure - B, respectively.
12-Jul-2024	19-Jul-2024	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday July 19 2024 inter-alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2024. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2024 and will continue to remain closed till 48 hours after the results are made public on July 19 2024. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Friday, July 19, 2024, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2024. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 03:00 p.m. and concluded at 5.45 p.m. Kindly take the above on record. (As Per BSE Announcement dated on 19.07.2024)
23-Apr-2024	30-Apr-2024	Accounts	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Tuesday April 30 2024 inter-alia to: 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31 2024. 2. Recommend dividend if any on Equity Shares of the Company for the financial year ended March 31 2024. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from April 1 2024 and will continue to remain closed till 48 hours after declaration of results on April 30 2024. Kindly take the same on record Final Dividend & Audited Results (As per BSE Bulletin dated on 23/04/2024) In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on Tuesday, April 30, 2024, inter-alia considered and unanimously The disclosures as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 and pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are enclosed herewith. The meeting commenced at 03:00 p.m. and concluded at 6.45 p.m Audited financial Results for quarter and year ended March 31, 2024. The details of appointment/reappointment of the Directors at the Board Meeting of the Company held on April 30, 2024 are attached. (As Per BSE Announcement dated on 30.04.2024)
25-Jan-2024	01-Feb-2024	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Thursday February 01 2024 inter-alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2023. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from January 01 2024 and will continue to remain closed till 48 hours after the results are made public on February 01 2024. Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Thursday, February 01, 2024, inter-alia Considered and approved items as mentioned in attachment. The meeting commenced at 02:00 p.m. and concluded at 05.30 p.m. Kindly take the above on record. RPG Life Sciences Limited has informed exchanges regarding Financial results for Quarter and Nine Months ended on December 31, 2023. Kindly take the same on record. (As per BSE Announcement Dated on 01/02/2024)
11-Oct-2023	18-Oct-2023	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Wednesday October 18 2023 inter-alia to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30 2023. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from October 1 2023 and will continue to remain closed till 48 hours after the results are made public on October 18 2023. Kindly take this information on record. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, October 18, 2023, inter-alia: 1.considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. 2.Execution of Power Delivery Agreement with Sunpound Solar Private Limited (Sunpound) a Special Purpose Vehicle (SPV), for supply of electricity by Power Producer to the Company, by setting up a group captive solar power project in Maharashtra. Details required as per SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1 /P/CI R/2023/123 dated July 13, 2023 are enclosed as Annexure - A. The meeting commenced at 03:00 p.m. and concluded at 06.00 p.m. Kindly take the above on record. RPG Life Sciences Limited has informed the exchanges regarding Financial results for quarter and half year ended September 30, 2023. (As Per BSE Announcement dated on 18.10.2023)
21-Jul-2023	28-Jul-2023	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday July 28 2023 inter-alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2023. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2023 and will continue to remain closed till 48 hours after the results are made public on July 28 2023. Kindly take this information on record. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Friday, July 28, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 03:00 p.m. and concluded at 5.30 p.m. Kindly take the above on record. (As per BSE Announcement Dated on 28/07/2023)
21-Apr-2023	28-Apr-2023	Accounts	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday April 28 2023 inter-alia to: 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31 2023. 2. Recommend dividend if any on Equity Shares of the Company for the financial year ended March 31 2023. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from April 1 2023 and will continue to remain closed till 48 hours after declaration of results on April 28 2023. Kindly take this information on record. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously: 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. Copy of the same is enclosed along with the Report of the Auditors thereon and a declaration stating that the said report is with unmodified opinion. 2. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. 3. Approved the Audited Financial Statements of the Company, for the year ended March 31, 2023. The Board meeting commenced at 3:00 p.m. and concluded at 6.35 p.m. Kindly take the above on record. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 28.04.2023)
25-Jan-2023	01-Feb-2023	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Wednesday February 01 2023 inter-alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2022. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from January 01 2023 and will continue to remain closed till 48 hours after the results are made public on February 01 2023. Kindly take this information on record. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, February 01, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 03:00 p.m. and concluded at 5.15 p.m. Kindly take the above on record. (As Per BSE Announcement Dated on 01/02/2023)
10-Oct-2022	17-Oct-2022	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Monday October 17 2022 inter-alia to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30 2022. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from October 1 2022 and will continue to remain closed till 48 hours after the results are made public on October 17 2022. Kindly take this information on record.
26-Jul-2022	02-Aug-2022	Quarterly Results	Quarterly Results RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Tuesday, August 2, 2022, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2022. Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from July 1, 2022 and will continue to remain closed till 48 hours after the results are made public on August 2, 2022. Kindly take this information on record. (As Per BSE Announcement dated on 26.07.2022) In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Tuesday, August 02, 2022, inter alia, considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2022 along with Limited Review Report of the Statutory Auditors thereon. The meeting commenced at 03:00 p.m. and concluded at 06:00 p.m. Kindly take the same on your record. (As Per BSE Announcement Dated on 02.08.2022)
22-Apr-2022	29-Apr-2022	Accounts	Audited Results RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 29, 2022, inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2022. Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2022 and will continue to remain closed till 48 hours after the results are made public on April 29, 2022. Kindly take this information on record. Recommended equity dividend of Rs. 9.60 per share of Rs. 8/- each (120%) for the financial year ended March 31, 2022, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. Outcome of the meeting of the Board of Directors of RPG Life Sciences Limited held on April 29, 2022, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m. (As Per BSE Announcement Dated on 29.04.2022)
18-Jan-2022	25-Jan-2022	Quarterly Results	RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2022 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2021. Further pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities by Designated Persons and their immediate relatives is closed from January 1 2022 and will continue to remain closed till 48 hours after the results are made public on January 25 2022. Kindly take this information on record. In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Tuesday, January 25, 2022, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021, along with Limited Review Report of the Statutory Auditors thereon. The meeting commenced at 03:00 p.m. and concluded at 05:15 p.m. Kindly take the above on record. Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31, 2021 which were approved by the Board of Directors of the Company, at its meeting held on January 25, 2022 along with Limited Review Report issued by the Statutory Auditors of the Company. The meeting commenced at 03:00 p.m. and concluded at 05:15 p.m. Kindly take the above on record. (As Per BSE Announcement dated on 25.01.2022)
18-Oct-2021	29-Oct-2021	Quarterly Results	Quarterly Results In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Friday, October 29, 2021, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021 along with Limited Review Report of the Statutory Auditors thereon. The meeting commenced at 03:00 p.m. and concluded at 05:20 p.m. Kindly take the above on record. (As Per BSE Announcement dated on 29.10.2021)

1 2

LOGIN HERE

RPG Life Sciences Ltd

Board Meeting